Can ESCALON MED CORP (OTCMKTS:ESMC)’s Tomorrow Be Different? The Stock Had Decline in Shorts

The stock of ESCALON MED CORP (OTCMKTS:ESMC) registered a decrease of 75% in short interest. ESMC’s total short interest was 100 shares in May as published by FINRA. Its down 75% from 400 shares, reported previously. With 2,000 shares average volume, it will take short sellers 0 days to cover their ESMC’s short positions.

The stock increased 1.85% or $0.002 during the last trading session, reaching $0.11. About 17,600 shares traded or 197.50% up from the average. Escalon Medical Corp. (OTCMKTS:ESMC) has 0.00% since May 17, 2018 and is . It has underperformed by 4.37% the S&P500.

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and Europe. The company has market cap of $815,685. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and pachymeter that measures the thickness of cornea. It currently has negative earnings. The firm also provides color/fluorescein angiography digital imaging systems that are primarily used in detecting retinal problems in diabetic and elderly patients; and Ispan intraocular gases, such as C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery, as well as a patented disposable universal gas kit that delivers the gas from the canister to the patient.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.